A new Government-funded research project is set to investigate the potential long-term health risks associated with vaping. The study aims to recruit 200 individuals who smoke and wish to quit, along with 40 individuals who have never smoked, to conduct an in-depth analysis of how vaping impacts the respiratory system over a year.
While the NHS continues to endorse e-cigarettes as a smoking cessation aid, concerns are rising regarding the increasing number of non-smoking youths adopting vaping. Existing research on the dangers of tobacco use, accumulated over decades, indicates that smoking poses significantly greater health risks compared to vaping. However, there remains a lack of conclusive evidence on the prolonged effects of vaping.
The Medical Research Council has allocated £1.5 million to finance a comprehensive trial that will explore the effects of vaping on lung cells, immune cells, inflammatory markers, and the “airway microbiome.” Professor David Thickett, leading the EVALUATE study at Birmingham University, emphasized the importance of generating essential data to enable individuals to make informed decisions about quitting smoking with e-cigarettes and determining the optimal duration of e-cigarette use post-smoking cessation.
E-cigarettes contain harmful substances such as nitrosamines, carcinogenic carbonyls, toxic metals, and volatile organic compounds. The groundbreaking study will investigate how e-cigarettes influence gene and protein expression patterns over time. Dr. Aaron Scott, the chief investigator at Birmingham University, highlighted the focus on examining the impact of vaping on critical airway immune cells and lung epithelial cells, which are pivotal in the development of smoking-related lung diseases.
Recent concerns raised at a major heart conference in Madrid about the emergence of a “vaping epidemic” and potential associated risks, including a reported one-third increase in stroke risk from e-cigarette use, have sparked further attention. Notably, top heart expert Prof Maja-Lisa Løchen advocated for restrictions on e-cigarette sales to prevent a potential public health crisis.
A review conducted by University College London revealed a significant rise in vaping rates among adults and young adults in recent years. To gain insights into the impact of vaping on lung health, the trial will enroll 200 healthy smokers from University Hospitals Birmingham NHS Foundation Trust’s stop smoking services, dividing them into groups using nicotine patches/gum or e-cigarettes. Additionally, 40 individuals who have never smoked or vaped will participate in the study, with samples collected over a year for lung health assessments.
Dr. Mike Cox, an expert in respiratory microbiome, emphasized the importance of understanding how vaping influences the airway microbiome, which plays a crucial role in maintaining overall health. By studying immune cells from blood and airways via bronchoscopy, Dr. Dhruv Parekh highlighted the comprehensive approach taken to assess the impact of vaping on airway health.
ASH, a prominent health charity, asserts that vaping is substantially less harmful than smoking and estimates that millions of individuals have successfully quit smoking through e-cigarette use. Norway recently lifted its ban on nicotine-containing vapes, permitting regulated sales with strict guidelines, including restrictions on flavors.
Individuals interested in participating in the study can contact University Hospitals Birmingham NHS staff smoking cessation services for further information.